SCHEMBL24014370

SCHEMBL24014370

CC(O)c1cc(F)ccc1BO

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CES2 O00748 2/20 0.35
▸ CES1 P23141 2/20 0.35
▸ KCNH2 Q12809 3/20 0.34
▸ PSEN1 P49768 3/20 0.33
▸ PSEN2 P49810 3/20 0.33
▸ APH1B Q8WW43 3/20 0.33
▸ NCSTN Q92542 3/20 0.33
▸ APH1A Q96BI3 3/20 0.33
▸ PSENEN Q9NZ42 3/20 0.33
▸ PDE2A O00408 2/20 0.33
▸ TRPA1 O75762 1/20 0.32
▸ HTR2A P28223 2/20 0.31
▸ HTR2C P28335 2/20 0.31
▸ GCGR P47871 1/20 0.31
▸ DPP4 P27487 1/20 0.30
▸ DPP8 Q6V1X1 1/20 0.30
▸ DPP9 Q86TI2 1/20 0.30
▸ DPP7 Q9UHL4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24007433 1.00 MEN1 (0.38) MEN1KMT2ACES2CES1KCNH2
SCHEMBL24007490 0.85 MEN1 (0.38) MEN1KMT2ACES2CES1KCNH2
SCHEMBL31035929 0.75 CES2 (0.52) MEN1KMT2ACES2CES1KCNH2
SCHEMBL2016730 0.75 CES2 (0.52) MEN1KMT2ACES2CES1KCNH2
SCHEMBL15854160 0.75 CES2 (0.52) MEN1KMT2ACES2CES1KCNH2
SCHEMBL265533 0.75 CES2 (0.52) MEN1KMT2ACES2CES1KCNH2
SCHEMBL21885998 0.74 ALOX15 (0.32) MEN1KMT2ATRPA1HTR2A
SCHEMBL24006637 0.74 MEN1 (0.41) MEN1KMT2ACES2CES1KCNH2
SCHEMBL16629395 0.74 MEN1 (0.41) MEN1KMT2ACES2CES1KCNH2
SCHEMBL16946707 0.74 CA3 (0.43) MEN1KMT2ACES2CES1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021226269-A1 HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS NUVALENT, INC. (US) 2021-11-11 — — WO disclosed
Send feedback